Rehabilitating Visual Deficits Caused by Stroke

University of Oxford20 enrolled

Overview

This research aims to understand the efficacy of a visual training task to improve visual loss after stroke, also known as hemianopia. The investigators aim to understand whether training can improve vision and which areas or pathways in the brain are responsible for this improvement.

Damage to the primary visual cortex (V1) due to stroke usually results in loss of visual function in half of the visual world, this is known as hemianopia. This visual loss can negatively affect quality of life, as most stroke survivors are no longer permitted to drive and have difficulties with navigation and socialising. There are currently limited treatment options, although recent evidence suggests that visual training can be effective in improving visual function (Huxlin et al, 2009; Cavanaugh \& Huxlin, 2017). The aim of this research is to determine the capacity for visual rehabilitation after stroke using visual training and to understand the underlying brain mechanisms that might drive these improvements. This study will help the investigators to understand the brain mechanisms involved in visual rehabilitation and may allow the investigators to predict those most likely to benefit from visual rehabilitation in the future. Twenty stroke survivors with hemi- or quadrantanopia will complete a 6-month visual motion discrimination training programme at home. Each participant will have three study visits; at baseline, 6-months and 9-months. At each visit the investigators will take measures of 1) visual fields 2) detailed tests of visual function 3) quality of life and 4) MRI scans of brain structure, function and neurochemistry. Between the baseline (0 month) and 6-month post-training session, participants will complete visual training at home. Between the 6-month post-training session and 9-month follow up, participants will not complete visual training at home. This study will therefore allow the investigators to determine whether rehabilitation improves conscious visual perception and quality of life as well as providing understanding of the neural mechanisms that underlie this improvement. The investigators will also determine whether improvements or neural changes persist after 3-months without training.

Study Type

INTERVENTIONAL

Allocation

Purpose

TREATMENT

Masking

NONE

Enrollment

Conditions

Hemianopia Hemianopsia Quadrantanopia Stroke Induced Vision Loss

Interventions

Training in the blind fieldBEHAVIORAL

Participants will complete visual training at two locations in the blind field. These two locations of training will be determined at the baseline study visit (0 months) and will be located within the perimetry-defined blind field. The training programme involves discriminating the direction of motion in a small circle of moving dots. The computer software and a chin-rest will be loaned to each participant to complete training at home. Participants will perform 300 trials at each location in their blind field, 5 days a week for at least 24 weeks (40-60 minutes in total). The computer programme will automatically generate a record of participant performance after each home training session.

Eligibility

Sex: ALLMin age: 18 YearsMax age: 80 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Aged 18-80 * Participant is willing and able to give informed consent for participation in the study * Fluent English-speaking healthy adults * Has suffered damage to the visual cortex at least 6 months before the study Exclusion Criteria: * Previous eye disease or impairment other than hemianopia * Neurological or psychiatric illness * Contraindication to MRI * Pregnant or breast feeding * Second stroke during training Data quality assurance (participant data will be removed from analysis for the following reasons): * Concurrent participation in other "vision therapy" * Unreliable visual fields, indicated by greater than 20% fixation losses, false positives, or false negatives * Inability to demonstrate fixation stability on eye movement monitored testing * Failure to complete at least 100 training sessions over 6-months

Locations (1)

Wellcome Centre For Integrative Neuroimaging, University of Oxford

Oxford, Oxfordshire, United Kingdom

RECRUITING

Outcomes

Primary Outcomes

Change in motion discrimination thresholds after 6 months of training

Change in normalised discrimination thresholds on psychophysical motion discrimination task at two trained locations between baseline (0-month) and 6-month follow up. These assessments will be based on what motion can be reliably detected at a 75% correct level of performance.

Time frame: 6 months

Secondary Outcomes

Maintenance of improvement in motion discrimination thresholds at 9-month follow up.

No change in normalised discrimination thresholds on psychophysical motion discrimination task at two trained locations between 6-month and 9-month follow up. These assessments will be based on what motion can be reliably detected at a 75% correct level of performance.

Time frame: 9 months

Change in area improved on the Humphrey perimetry (24-2 and 10-2)

Change in area improved on a composite measure of deficit size calculated from 24-2 and 10-2 across both eyes. Area of improvement will be calculated as the area where the sensitivity improved by more than 6 decibels (dB) relative to pre-training.

Time frame: 6 months

Maintenance area improved on the Humphrey perimetry (24-2 and 10-2)

No change in area improved on a composite measure of deficit size calculated from 24-2 and 10-2 across both eyes. Area of improvement will be calculated as the area where the sensitivity improved by more than 6dB relative to pre-training.

Time frame: 9 months

Change in contrast detection at trained locations

Change in detection of stimulus at 1%, 5%, 10%, 50% and 100% contrast baseline (0-month) and 6-month follow up.

Time frame: 6 months

Maintenance contrast detection at trained locations

Central Contacts

Hannah Willis, MPsych

CONTACT

01865 611458 hannah.willis@ndcn.ox.ac.uk

Holly Bridge, PhD

CONTACT

01865 610482 holly.bridge@ndcn.ox.ac.uk

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.